Clinical Trial Update: A Study of GC101 TIL in Advanced Breast Cancer (10hospital) [EARLY_Phase 1]

View source ↗

Summary

An early-phase study evaluating GC101 TIL therapy for advanced breast cancer, currently recruiting at 10 hospitals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• GC101 TIL

Snippet

Sponsor: Shanghai Juncell Therapeutics | Conditions: Breast Cancer, Treatment Side Effects | EARLY_Phase 1 | Status: RECRUITING